Vascular Imaging Market Report 2026

The vascular imaging market size has grown strongly in recent years. It will grow from $6.51 billion in 2025 to $6.89 billion in 2026 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to expansion of diagnostic imaging infrastructure, increasing prevalence of cardiovascular diseases, growing utilization of angiography procedures, improved access to advanced imaging equipment, rising clinical demand for accurate diagnostics.

The vascular imaging market size is expected to see strong growth in the next few years. It will grow to $8.66 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing investments in precision diagnostics, growing adoption of ai-driven imaging software, expansion of outpatient diagnostic imaging centers, rising focus on early disease detection, increasing integration of imaging with treatment planning. Major trends in the forecast period include increasing adoption of advanced vascular imaging modalities, rising use of AI-assisted image analysis, growing demand for high-resolution diagnostic imaging, expansion of non-invasive vascular assessment techniques, enhanced integration of multimodal imaging systems.

The rising incidence of hypertension is expected to drive growth in the vascular imaging market in the coming years. Hypertension, or high blood pressure, is a condition in which the force of blood against the artery walls remains consistently elevated. It can result in serious health complications, including heart disease and stroke. The increasing prevalence of hypertension is linked to lifestyle factors such as unhealthy diet, physical inactivity, and stress, as well as rising obesity rates and aging populations. Vascular imaging is crucial in the management of hypertension, as it assesses vascular structure and function, supporting the diagnosis and treatment of underlying vascular abnormalities that contribute to elevated blood pressure. For instance, in March 2024, data from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that hypertension prevalence was higher among men (33.2%) than women (27%), higher among adults aged ≥65 years (60.6%) compared to those aged 18-44 years (14.5%) and 45-64 years (40.3%), higher among Black adults (40.2%) compared to Asian adults (22.7%), and higher among individuals with less than a high school education (33.8%) compared to those with some college (31.2%) or a college degree or higher (25.5%). Therefore, the increasing incidence of hypertension is fueling the growth of the vascular imaging market.

Major companies operating in the vascular imaging market are focusing on the development of innovative technologies, such as wireless ultrasound imaging systems, to improve diagnostic capabilities and enhance patient care. Wireless ultrasound imaging systems are portable ultrasound devices that transmit imaging data wirelessly, offering increased flexibility and mobility in clinical settings. For instance, in August 2023, GE HealthCare Technologies Inc., a US-based medical technology company, launched the Vscan Air SL, a handheld, wireless ultrasound imaging system designed for rapid cardiac and vascular assessments at the point of care, helping clinicians accelerate diagnosis and treatment planning. As an upgrade to the Vscan series, Vscan Air SL incorporates GE Healthcare’s SignalMax and XDclear technologies, delivering high-quality imaging with exceptional penetration, resolution, and sensitivity, powered by advanced single-crystal transducer technology.

In March 2024, DirectMed Imaging, a US-based provider of medical imaging equipment, parts, and services, acquired Titanium Medical Imaging for an undisclosed sum. This acquisition is expected to strengthen DirectMed Imaging’s portfolio and expand its global presence in the medical imaging market. Titanium Medical Imaging is a US-based company specializing in diagnostic imaging solutions for X-ray, magnetic resonance imaging, and computed tomography systems.

Major companies operating in the vascular imaging market are Hitachi Ltd., Siemens AG, General Electric Company, Abbott Laboratories, Toshiba Corporation, FUJIFILM Corporation, Koninklijke Philips N.V., Stryker Corporation, Konica Minolta Inc., Terumo Corporation, Hologic Inc., Mindray Medical International Limited, Shimadzu Corporation, Canon Medical Systems Corporation, Samsung Medison Co. Ltd., Esaote SpA, BK Medical Holding Company Inc., Lumedx Corp, Alpinion Medical Systems Co. Ltd., CorVascular Diagnostics LLC.

North America was the largest region in the vascular imaging market in 2025. The regions covered in the vascular imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the vascular imaging market by increasing costs of imported imaging systems, detectors, contrast agents, software platforms, and electronic components used in MRI, CT, ultrasound, and x-ray systems. Hospitals and diagnostic imaging centers in North America and Europe are most affected due to reliance on imported high-value imaging equipment, while Asia-Pacific faces higher costs for advanced imaging imports. These tariffs are raising capital expenditure and slowing equipment upgrades. However, they are also encouraging local assembly, regional technology development, and domestic manufacturing of imaging components, supporting long-term market stability.

The vascular imaging market research report is one of a series of new reports that provides vascular imaging market statistics, including vascular imaging industry global market size, regional shares, competitors with a vascular imaging market share, detailed vascular imaging market segments, market trends and opportunities, and any further data you may need to thrive in the vascular imaging industry. This vascular imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vascular imaging involves the use of various imaging techniques and technologies to visualize and evaluate the blood vessels in the human body. These methods are essential for diagnosing and monitoring vascular conditions such as arterial and venous diseases, aneurysms, and blockages, and play a key role in the effective management of vascular disorders.

The primary techniques used in vascular imaging include magnetic resonance imaging, ultrasound, computed tomography, nuclear imaging, and x-ray. Magnetic resonance imaging (MRI) is a non-invasive imaging method that utilizes magnetic fields and radio waves to produce detailed images of the body's internal structures. Procedures include coronary angiography, peripheral angiography, neurovascular angiography, vascular ultrasound procedures, microangiography, and others, for applications such as diagnostic and therapeutic purposes. End users include hospitals, diagnostic imaging centers, and other healthcare facilities.

The vascular imaging market consists of revenues earned by entities by providing services such as magnetic resonance angiography (MRA), computed tomography angiography (CTA), traditional angiography, consultative services, and diagnostic interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular imaging market also includes sales of contrast agents and embolic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.